SZD fundamentals
An in-depth look to SANTEN PHARMA. operating, investing, and financing activities
SZD free cash flow for Q4 23 is 60.61 M EUR. For 2023, SZD free cash flow was 387.79 M EUR and operating cash flow was 444.85 M EUR.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM